Aptevo Therapeutics

Aptevo Therapeutics is a biotechnology company focused on introducing novel oncology and hematology therapeutic technologies to the market. Leveraging its innovative ADAPTIR™ platform technology and unique cancer immunotherapy approaches, the company aims to improve treatment outcomes for cancer patients. Headquartered in Seattle, Washington, Aptevo takes pride in its strong work environment, entrepreneurial culture, and proprietary platform technology. This enables Aptevo to attract some of the most innovative talents in the field. Many of our team members have experience collaborating with other leading biotechnology companies, including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.